DRUG PROMOTION IN IRAQ AND ITS NEGATIVE EFFECT ON BOTH PERSONAL AND COUNTRY BUDGET
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 1
Abstract
No abstract since it is just a letter to editor
Authors and Affiliations
Ehab Mudher Mikhael
Keywords
Related Articles
- EP ID EP579147
- DOI -
- Views 65
- Downloads 0
A NEW STABILITY INDICATING UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF METOLAZONE AND SPIRONOLACTONE IN BULK AND IN ITS PHARMACEUTICAL FORMULATIONS
Objective: The objective of the work is to develop and validate a new, simple, highly sensitive RP-UPLC method for simultaneous estimation of Metolazone and Spironolactone in bulk and in its dosage forms. Methods: The me...
EXPRESSION AND ENZYMATIC PROPERTIES OF A UNIQUE RECOMBINANT ANTICOAGULANT AND FIBRINOLYTIC ENZYME FROM ACINETOBACTER BAUMANNII TU04
Objective: The objective of this research is to clone and express a new fibrinolytic enzyme encoding serine protease gene in Escherichia coli thus, characterize such purified recombinant.Methods: The recombinant clone wa...
EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF HELICIA NILAGIRICA BEDD ON COTTON PELLET-INDUCED GRANULOMA IN RATS
Objective: The present study was undertaken to screen the anti-inflammatory activity of Helicia nilagirica Bedd., an ethnomedicinal plant of Mizoram, India.Methods: In this study inflammation was induced by cotton pellet...
STUDY OF ENHANCED ANTI-INFLAMMATORY POTENTIAL OF NIGELLA SATIVA IN TOPICAL NANOFORMULATION
Objective: Formulate a nanocarrier for enhancing the anti-inflammatory activity of thymoquinone (Tq), a major active constituent of Nigella sativa.Methods: Nanoformulation of Tq was developed by low energy emulsification...
DOCKING AND CYTOTOXICITY STUDIES OF 2-VINYLCHROMONE DERIVATIVES ON HUMAN BREAST CANCER CELL LINES
Objective: Estrogen receptor (ER) is over-expressed in 70% of breast cancers. The ER has two isoforms, ERα and ERβ. The ER ligand binding domain (LBD) has been the target for hormone-responsive breast cancer. Due to ti...